Collection: Biliary tract cancer KRAS-G12C
-
Adalacilib is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring a KRAS G12C mutation who have received at least one prior systemic therapy.
Regular price ¥3,300.00 CNYRegular priceUnit price / per¥6,000.00 CNYSale price ¥3,300.00 CNYSale -
Adagrasib,ADADX,Adagrasib,200mg
Regular price ¥3,300.00 CNYRegular priceUnit price / per¥5,800.00 CNYSale price ¥3,300.00 CNYSale